Prices are updated after-hours

Medicenna Therapeutics Corp.

MDNA | $0.157 -0.32% 1.3M

(0.0% 1d) (0.0% 1m) (-76.2% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (167.34% volume)
Earnings Calendar: 2023-10-26
Market Cap: $ 10,933,083
http://www.medicenna.com
Sec Filling | Patents | 7 employees

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company which engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.

cancer treatment

add to watch list Paper trade email alert is off

COMPAGNIE DE SAINT GOBAIN

CODGF | $75.205 -37.16% 180

Producer Manufacturing

(0.0% 1d) (-1.2% 1m) (34.6% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (3400.0% volume)
Earnings Calendar:
Market Cap: $ 38,087,798,767
http://www.saint-gobain.com
Sec Filling | Patents | n/a employees

(FR) Compagnie de Saint-Gobain SA engages in the production and distribution of construction materials. It operates through the following business segments: Innovative Materials, Construction Products, and Building Distribution. The Innovative Materials segment offers a unique portfolio of materials and processes for the habitat and industrial markets. The Construction Products segment offers interior and exterior solutions to enhance the comfort of buildings and homes, including plaster, acoustic and thermal insulation, wall facing, roofing and pipe systems. The Building Distribution segment serves the new building, renovation and home improvement markets. The company was founded in 1665 and is headquartered in Courbevoie, France.

construction insulation

add to watch list Paper trade email alert is off

Evotec SE

EVOTF | $21.68 30.35% 3.2K

Health Technology

(0.0% 1d) (0.0% 1m) (14.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (2361.54% volume)
Earnings Calendar:
Market Cap: $ 3,561,433,458
http://evotec.com
Sec Filling | Patents | n/a employees

(DE) Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmes on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.

drug discovery

add to watch list Paper trade email alert is off

SEIKO EPSON CORP

SEKEF | $14.2 -1.18% 1.8% 0

Electronic Technology

(0.0% 1d) (0.0% 1m) (-3.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (0.0% volume)
Earnings Calendar:
Market Cap: $ 5,467,316,348
http://www.epson.jp
Sec Filling | Patents | n/a employees

(JP) Seiko Epson Corp. engages in the development, manufacture, and sale of information equipment. It operates through the following business segments: Printing Solutions, Visual Communications, and Wearable & Industrial Products. The Printing Solutions segment offers Inkjet printers, serial impact dot matrix printers, page printers, color image scanners, large-format inkjet printers, industrial inkjet printing systems, printers for use in POS systems, label printers and related consumables, office papermaking systems, personal computers and others. The Visual Communications segment offers 3LCD projectors, HTPS-TFT panels for 3LCD projectors, smart eyewear and others. The Wearable & Industrial Products segment offers watches, watch movements, sensing equipment, industrial robots, IC handlers, crystal units, crystal oscillators, quartz sensors, CMOS LSIs, metal powders, surface finishing and others. The company was founded on May 18, 1942 and is headquartered in Suwa, Japan.

communication computational sensor

add to watch list Paper trade email alert is off

Andritz AG

ADRZF | News | $58.8 -0.83% 1.5K

Producer Manufacturing

(0.0% 1d) (0.0% 1m) (8.2% 1y) (0.0% 2d) (-1.1% 3d) (0.0% 7d) (-18.75% volume)
Earnings Calendar:
Market Cap: $ 6,115,200,000
http://www.andritz.com
Sec Filling | Patents | n/a employees

(AT) Andritz AG engages in the provision of plants, equipment and services for hydropower stations. It operates through the following segments: Hydro; Pulp & Paper; Metals; and Separation. The Hydro segment installs and offers electromechanical systems, pumps, and hydropower equipment. The Pulp & Paper segment manufactures and trades tissue, board, and paper products. The Metals segment processes cold-rolled carbon steel, metal strip, and stainless steel. The Separation segment produces belts, screw passes, screens, drains cantrifuges, discs, drum filters, filter presses, separators, thickeners, flocculent systems, and thermal systems. The company was founded by Josef Körösi in 1852 and is headquartered in Graz, Austria.

hydroponic

add to watch list Paper trade email alert is off

BeiGene, Ltd.

BEIGF | $14.29 -9.87% 2.1K

n/a

(0.0% 1d) (0.0% 1m) (-14.8% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (366.67% volume)
Earnings Calendar:
Market Cap: $ 18,387,425,502
http://www.beigene.com/
Sec Filling | Patents | 5300 employees

(China (Mainland)) beigene is a chinese life sciences biotechnology company based in beijing that is focused on discovering and developing innovative oncology drugs that will address unmet medical needs in cancers that are prevalent in china and the asia-pacific region.

add to watch list Paper trade email alert is off

Technicolor

TCLRY | $0.001 1000.0% 140K

Manufacturing

(0.0% 1d) (0.0% 1m) (-90.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (482.33% volume)
Earnings Calendar:
Market Cap: $ 9,596,094
https://www.technicolor.com/fr
Sec Filling | Patents | n/a employees

(FR)

add to watch list Paper trade email alert is off

Poseida Therapeutics, Inc.

PSTX | $2.16 0.23% -0.23% 420K

Health Technology

(0.0% 1d) (-28.9% 1m) (-15.3% 1y) (0.0% 2d) (0.5% 3d) (5.6% 7d) (-23.62% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 208,416,514
http://www.poseida.com
Sec Filling | Patents | 149 employees

(US) Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in 2014 and is headquartered in San Diego, CA.

car-t t-cell treatment ceiling

add to watch list Paper trade email alert is off

PubMatic Inc - Class A

PUBM C | $22.84 3.02% 2.81% 280K

(0.0% 1d) (-2.0% 1m) (68.8% 1y) (0.0% 2d) (3.0% 3d) (5.7% 7d) (46.94% volume)
Earnings Calendar: 2024-02-26
Market Cap: $ 948,518,660
https://pubmatic.com
Sec Filling | Patents | 548 employees

PubMatic, Inc. delivers superior revenue to publishers by being a sell-side platform of choice for agencies and advertisers. The PubMatic platform empowers independent app developers and publishers to maximize their digital advertising monetization while enabling advertisers to increase ROI by reaching and engaging their target audiences in brand-safe, premium environments across ad formats and devices. Since 2006, PubMatic has created an efficient, global infrastructure and remains at the forefront of programmatic innovation. Headquartered in Redwood City, California, PubMatic operates 14 offices and eight data centers worldwide.

digital advertising brands

add to watch list Paper trade email alert is off

RenovoRx Inc

RNXT | $1.2 -2.44% 4.88% 2.9K

(0.0% 1d) (-16.1% 1m) (-56.2% 1y) (0.0% 2d) (-2.4% 3d) (2.6% 7d) (-32.93% volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 28,739,796
https://www.renovorx.com
Sec Filling | Patents | 2021 employees

RenovoRx, a biopharmaceutical company headquartered in Silicon Valley, California, has developed a therapy platform targeting difficult-to-treat tumors. Targeted therapy via the proprietary RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMP) platform safely and without transmission to non-targeted areas, is the primary focus. RenovoRx's patent portfolio includes seven U.S. patents for its technology. The Company also has secured two separate Orphan Drug Designations from the FDA for intra-arterial gemcitabine including pancreatic cancer and bile duct cancer. The RenovoTAMP therapy is being studied in the Phase III TIGeR-PaC trial for the treatment of locally advanced pancreatic cancer. RenovoRx won the Drug Delivery Technology category of the Fierce Innovation Awards – Life Sciences Edition 2020 for its RenovoTAMP technology.

treatment cancer urea security pancreatic

add to watch list Paper trade email alert is off

Revolution Medicines, Inc.

RVMD | $36.26 -0.47% -0.5% 1.4M

Health Technology

(0.0% 1d) (19.4% 1m) (57.2% 1y) (0.0% 2d) (-0.5% 3d) (3.8% 7d) (49.12% volume)
Earnings Calendar: 2024-02-26
Market Cap: $ 5,971,659,400
http://www.revmed.com
Sec Filling | Patents | 95 employees

(US) Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

cancer treatment cancer treatments

add to watch list Paper trade email alert is off

Boston Beer Company, Inc. (The)

SAM | $286.1 -1.07% 0.0% 140K

Consumer Non-Durables

(0.0% 1d) (-7.7% 1m) (-9.3% 1y) (0.0% 2d) (-1.1% 3d) (-0.3% 7d) (-8.16% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 2,848,560,372
http://www.bostonbeer.com
Sec Filling | Patents | 2128 employees

(US) Boston Beer Co., Inc. engages in the business of alcoholic beverages. Its brands include Samuel Adams, Twisted Tea, Angry Orchard, and Truly Hard Seltzer. The company was founded by C. James Koch in 1984 and is headquartered in Boston, MA.

brands

add to watch list Paper trade email alert is off

SAB Biotherapeutics Inc

SABS | $4.36 -0.68% 7.54% 860

(0.0% 1d) (2.6% 1m) (462.6% 1y) (0.0% 2d) (-0.7% 3d) (1.6% 7d) (-50.72% volume)
Earnings Calendar: 2023-11-13
Market Cap: $ 40,223,154
https://www.sabbiotherapeutics.com
Sec Filling | Patents | 5 employees

SAB Biotherapeutics, Inc. (SAB) is a clinical-stage, biopharmaceutical company advancing a new class of immunotherapies leveraging fully human polyclonal antibodies. SAB has applied advanced genetic engineering and antibody science to develop transchromosomic (Tc) Bovine™ that produce fully-human antibodies targeted at specific diseases, including infectious diseases such as COVID-19 and influenza, immune system disorders including type 1 diabetes and organ transplantation, and cancer. SAB’s versatile DiversitAb™ platform is applicable to a wide range of serious unmet needs in human diseases. It produces natural, specifically targeted, high-potency, human polyclonal immunotherapies. SAB is currently advancing multiple clinical programs and has collaborations with the US government and global pharmaceutical companies.

genetic cancer diabetes diabetic influenza covid

add to watch list Paper trade email alert is off

SEIKO EPSON CORP

SEKEY | $8.91 5.32% -1.89% 35K

Manufacturing

(0.0% 1d) (4.2% 1m) (21.8% 1y) (0.0% 2d) (0.4% 3d) (5.8% 7d) (-25.06% volume)
Earnings Calendar:
Market Cap: $ 6,861,096,994
https://www.epson.jp/
Sec Filling | Patents | n/a employees

(JP)

add to watch list Paper trade email alert is off

SFL Corporation Ltd

SFL | $13.0 1.48% 0.0% 400K

Transportation

(0.0% 1d) (-1.7% 1m) (45.1% 1y) (0.0% 2d) (2.7% 3d) (2.3% 7d) (Infinity% volume)
Earnings Calendar: 2024-02-14
Market Cap: $ 1,801,308,249
http://www.shipfinance.bm
Sec Filling | Patents | 11 employees

(BM) SFL Corp. Ltd. engages in the ownership and operation of vessels and offshore related assets. It also involves in the charter, purchase, and sale of assets. It operate through subsidiaries located in Bermuda, Cyprus, Malta, Liberia, Norway, the United Kingdom, and the Marshall Islands. The company was founded on October 10, 2003 and is headquartered in Hamilton, Bermuda.

add to watch list Paper trade email alert is off

SL Green Realty Corp

SLG | $52.41 3.21% 0.84% 750K

Finance

(0.0% 1d) (-0.3% 1m) (126.5% 1y) (0.0% 2d) (3.2% 3d) (2.2% 7d) (-32.79% volume)
Earnings Calendar: 2024-01-24
Market Cap: $ 3,451,661,280
http://www.slgreen.com
Sec Filling | Patents | 1033 employees

SL Green Realty Corp. operates as a real estate investment trust. The firm engages in the acquisition, development, ownership, management and operation of commercial and residential real estate properties. It operates through the Real Estate, and Debt and Preferred Equity Investments business segments. The Real Estate segment consists of security, maintenance, utility costs, real estate taxes, and at certain properties ground rent expense. The Debt and Preferred Equity Investments segment includes cash flow from operations, cash on hand, and other forms of secured or unsecured financing. The company was founded by Stephen L. Green in June 1997 and is headquartered in New York, NY.

acquisitions security nash msa

add to watch list Paper trade email alert is off

Scotts Miracle-Gro Company (The)

SMG | News | $68.58 1.02% 1.04% 450K

Process Industries

(0.0% 1d) (-5.5% 1m) (-0.3% 1y) (0.0% 2d) (1.0% 3d) (2.8% 7d) (-7.79% volume)
Earnings Calendar: 2024-02-07
Market Cap: $ 3,887,958,757
http://www.scottsmiraclegro.com
Sec Filling | Patents | 5932 employees

Scotts Miracle-Gro Co. engages in the manufacture, marketing, and distribution of systems and accessories for hydroponic gardening. It operates through the following segments: U.S. Consumer, Hawthorne, and Other. The U.S. Consumer segment consists of consumer lawn and garden business. The Hawthorn segment includes indoor, urban, and hydroponic gardening business. The Other segment refers to the consumer lawn and garden business in geographies other than the U.S. and product sales to commercial nurseries, greenhouses, and other professional customers. The company was founded by Orlando McLean Scott in 1868 and is headquartered in Marysville, OH.

hydroponic

add to watch list Paper trade email alert is off

Smart for Life Inc

SMFL | $4.68 7.59% 5.23% 16M

Manufacturing

(0.0% 1d) (444.2% 1m) (-1.9% 1y) (0.0% 2d) (0.0% 3d) (821.3% 7d) (425.17% volume)
Earnings Calendar:
Market Cap: $ 3,728,397

Sec Filling | Patents | 2021 employees

well-known for its popularity from clients across the u.s. and canada, the smart for life® cookie diet is more than just a weight loss company. it is committed to helping its clients lose weight, gain health and positively impact the environment along the way. over the past 7 years, smart for life® has helped hundreds of thousands of people lose hundreds of thousands of pounds - improving their health, appearance and happiness. founded by dr. sasson moulavi, md, a bariatric physician, smart for life® is based on his realizations of how food affects our health and uses the american society of bariatric physicians (asbp) guidelines. the asbp is a 50-year old organization teaching physicians the fundamentals of weight loss. smart for life® recognizes that food should be free of chemicals such as pesticides and preservatives, and produces its food with triple-filtered water and pesticide-free organic food ingredients. in order to truly compete with the wide variety of unhealthy fast food a

add to watch list Paper trade email alert is off

Smith & Nephew SNATS, Inc.

SNN | $24.8 1.81% -0.85% 1.2M

Health Technology

(0.0% 1d) (-4.0% 1m) (-21.3% 1y) (0.0% 2d) (1.8% 3d) (3.3% 7d) (-10.12% volume)
Earnings Calendar:
Market Cap: $ 10,841,751,793
http://smith-nephew.com/
Sec Filling | Patents | 17637 employees

Smith & Nephew Plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies and ENT. The Advanced Wound Management segment comprises advanced wound care, advanced wound bioactives and advanced wound devices businesses. The company was founded by Thomas James Smith in 1856 and is headquartered in London, the United Kingdom.

add to watch list Paper trade email alert is off

Sonder Holdings Inc - Class A

SOND | $4.4 1.38% 2.91% 37K

Administrative and Support and ...

(0.0% 1d) (30.2% 1m) (907.1% 1y) (0.0% 2d) (1.4% 3d) (-9.3% 7d) (14.29% volume)
Earnings Calendar: 2023-11-08
Market Cap: $ 48,684,847

Sec Filling | Patents | 3 employees

add to watch list Paper trade email alert is off